Filed before 2025Filed 7 September 2021
Nutcracker Therapeutics, Inc. raised $144M
Nutcracker Therapeutics, Inc., a biotech company based in Emeryville, CA, raised $144M in a new equity round, according to a filing dated 7 September 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 7 September 2021
- Round
- Equity round
- Amount sold
- $144M
- Offering size
- $200M
- Investors so far
- 14
- Based in
- Emeryville, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 94% of the 2,220 tracked raises with an amount filed in 2021, and than 94% of the 177 in biotech.
Nutcracker Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 7 Sep 2021 | New filing | $144M | This raise |
| 19 May 2020 | New filing | $14M | Another raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.